FIELD: medicine, cardiology. SUBSTANCE: method involves the use of thymogen by intravenous route before arrhythmia induction in experiment. Use of preparation decreases probability of arrhythmia rise and increases animals viability significantly. EFFECT: enhanced effectiveness of method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO PREVENT AFTEREFFECTS AND COMPLICATIONS OF INDUCED CARDIAC ISCHEMIA | 1993 |
|
RU2083219C1 |
| FUNCTIONALLY SUBSTITUTED 1-PHENYLOLIGOOXYETHYLAMINES MANIFESTING ANTIARRYTHMIC ACTIVITY | 1997 |
|
RU2141941C1 |
| MEDICINAL PREPARATION "CARDIOTRON" SHOWING ANTIARRHYTHMIC ACTION | 1994 |
|
RU2071782C1 |
| METHOD OF TREATING ISCHEMIC HEART DISEASE | 1996 |
|
RU2127117C1 |
| ANTIARRYTHMIC AGENT | 1983 |
|
RU2068261C1 |
| AGENT EXHIBITING ANTIARRHYTHMIC ACTIVITY | 2014 |
|
RU2565404C1 |
| THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| ARYLALIPHATIC AMINOAMIDES OF BENZOIC (SUBSTITUTED BENZOIC), CYCLOHEXANE- AND 1-ADAMANTANE CARBOXYLIC ACIDS SHOWING ANTI-ARRHYTHMIC, TOPICAL ANESTHETIC AND ANALGETIC ACTIVITY | 1996 |
|
RU2130922C1 |
| SUCCINIC ACID ESTER 5-HYDROXYADAMANTAN-2-ONE, WHICH PREVENTS THE DEVELOPMENT OF CARDIAC ARRHYTHMIAS | 2020 |
|
RU2757477C1 |
